Search Results - "Giacomini, Arianna"
-
1
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
Published in Pharmacology & therapeutics (Oxford) (01-11-2017)“…Originally characterized as angiogenic factors, fibroblast growth factors (FGFs) are pleiotropic factors that exert autocrine and paracrine functions on tumor…”
Get full text
Journal Article -
2
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
Published in Expert opinion on therapeutic targets (03-10-2015)“…Fibroblast growth factors (FGFs) are endowed with a potent pro-angiogenic activity. Activation of the FGF/FGF receptor (FGFR) system occurs in a variety of…”
Get more information
Journal Article -
3
Future applications of FGF/FGFR inhibitors in cancer
Published in Expert review of anticancer therapy (02-09-2018)“…Introduction: Deregulation of the fibroblast growth factor (FGF)/FGF receptor (FGFR) network occurs frequently in tumors due to gene amplification, activating…”
Get full text
Journal Article -
4
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy
Published in Cancer cell (10-08-2015)“…The fibroblast growth factor (FGF)/FGF receptor (FGFR) system plays a crucial role in cancer by affecting tumor growth, angiogenesis, drug resistance, and…”
Get full text
Journal Article -
5
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease
Published in International journal of molecular sciences (14-05-2019)“…We performed a three-dimensional (3D) analysis of the microvascular network of the cerebral cortex of twitcher mice (an authentic model of Krabbe disease)…”
Get full text
Journal Article -
6
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer
Published in Pharmacological research (01-03-2023)“…In spite of the huge advancements in both diagnosis and interventions, hormone refractory prostate cancer (HRPC) remains a major hurdle in prostate cancer…”
Get full text
Journal Article -
7
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress
Published in International journal of molecular sciences (09-12-2020)“…Lung cancer represents an extremely diffused neoplastic disorder with different histological/molecular features. Among the different lung tumors,…”
Get full text
Journal Article -
8
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity
Published in Pharmacological research (01-08-2024)“…Fibroblast growth factors (FGFs) act as proangiogenic and mitogenic cytokines in several cancers, including multiple myeloma (MM). Indeed, corrupted FGF…”
Get full text
Journal Article -
9
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma
Published in International journal of molecular sciences (17-09-2019)“…Fibrosarcoma is an aggressive subtype of soft tissue sarcoma categorized in infantile/congenital-type and adult-type. Fibrosarcoma cells and its surrounding…”
Get full text
Journal Article -
10
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
Published in Journal of experimental & clinical cancer research (01-11-2024)“…Among blood cancers, multiple myeloma (MM) represents the second most common neoplasm and is characterized by the accumulation and proliferation of monoclonal…”
Get full text
Journal Article -
11
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors
Published in Journal of medicinal chemistry (26-05-2016)“…NSC12 is an orally available pan-FGF trap able to inhibit FGF2/FGFR interaction and endowed with promising antitumor activity. It was identified by virtual…”
Get full text
Journal Article -
12
FGF-trapping hampers cancer stem-like cells in uveal melanoma
Published in Cancer cell international (11-05-2023)“…Cancer stem-like cells (CSCs) are a subpopulation of tumor cells responsible for tumor initiation, metastasis, chemoresistance, and relapse. Recently, CSCs…”
Get full text
Journal Article -
13
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
Published in International journal of molecular sciences (30-12-2019)“…Krabbe disease (KD) is an autosomal recessive sphingolipidosis caused by the deficiency of the lysosomal hydrolase β-galactosylceramidase (GALC)…”
Get full text
Journal Article -
14
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination
Published in Experimental hematology & oncology (01-11-2022)“…Abstract The lymphatic vascular system represents a major route for dissemination of several solid tumors, including melanoma. Even though the members of the…”
Get full text
Journal Article -
15
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
Published in Pharmaceuticals (Basel, Switzerland) (02-09-2019)“…Ribonucleotide reductase (RR) is the rate-limiting enzyme that controls the deoxynucleotide triphosphate synthesis and it is an important target of cancer…”
Get full text
Journal Article -
16
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth
Published in Frontiers in oncology (01-11-2018)“…Fibrosarcomas are soft tissue mesenchymal tumors originating from transformed fibroblasts. Fibroblast growth factor-2 (FGF2) and its tyrosine-kinase receptors…”
Get full text
Journal Article -
17
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma
Published in Frontiers in oncology (08-01-2021)“…The endothelin-1 (ET-1) receptors were recently found to mediate pro-survival functions in multiple myeloma (MM) cells in response to autocrine ET-1. This…”
Get full text
Journal Article -
18
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer
Published in Cell death discovery (06-03-2023)“…Prostate cancer (PCa) is a leading cause of death in the male population commonly treated with androgen deprivation therapy that often relapses as…”
Get full text
Journal Article -
19
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
Published in Experimental hematology & oncology (25-09-2023)“…Abstract Background The pattern recognition receptor long pentraxin-3 (PTX3) plays conflicting roles in cancer by acting as an oncosuppressor or as a pro-tumor…”
Get full text
Journal Article -
20
(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies
Published in PloS one (26-03-2013)“…Quantitative characterization of the in vivo effects of vascular-targeted therapies on tumor vessels is hampered by the absence of useful 3D vascular network…”
Get full text
Journal Article